Breakout Labs

About The Fund

Breakout Labs is a nonprofit seed-stage fund and an accelerator focused on catalyzing the growth of early-stage startups operating at the intersection of technology and science. Based in San Francisco, California, it provides grants to innovative companies that are forging new paths in a variety of industries, including IT, TMT, BioTech, Business Solutions, FinTech, Financials services, Hardware, Manufacturing, Energy, A.I., Big Data, Logistics, Distribution, Investment Management, and Life Science. With a keen interest in bio-based solutions, Breakout Labs is dedicated to improving human health and advancing the sustainability of the planet. Their investment approach involves partnering with founding teams who are committed to exploring novel hypotheses that have the potential for significant impact and opportunity when scaled. This involves helping these companies to reach critical milestones to build value and bring their vision to fruition. Breakout Labs prides itself on its decade-long history of supporting science-driven companies as they move with urgency through the developmental stages. Their portfolio includes companies like CYTOVALE focusing on diagnosing immune-mediated diseases, MODERN MEADOW with sustainable biofabrication, STRM.BIO in in vivo gene therapy, Immusoft for genetically modifying B cells for sustained protein-producing therapeutics, Noetik with advanced machine learning methods for cancer immunotherapies, and Twelve for carbon transformation. Moreover, Breakout Labs extends a supportive network of brilliant minds, life-long connections, and broad perspectives to its entrepreneurs, emphasizing a partnership that can endure the trials and triumphs of the startup journey. By investing in early-stage companies, Breakout Labs is at the forefront of the evolving landscape of intelligent biosciences and where innovation meets practical application.